These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 6416978)

  • 1. Hyperprolactinemia in hepatic encephalopathy: the effect of infusion of an amino acid mixture with excess branched chain amino acids.
    Bauer AG; Wilson JH; Lamberts SW; Blom W
    Hepatogastroenterology; 1983 Oct; 30(5):174-7. PubMed ID: 6416978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amino acids in hepatic encephalopathy--effects of branched chain amino acid infusion on serum aminogram.
    Watanabe A; Takesue A; Higashi T; Nagashima N
    Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):346-57. PubMed ID: 525213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial.
    Kanematsu T; Koyanagi N; Matsumata T; Kitano S; Takenaka K; Sugimachi K
    Surgery; 1988 Sep; 104(3):482-8. PubMed ID: 2842882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective amono acid solutions in hepatic encephalopathy treatment (a preliminary report).
    Fiaccadori F; Ghinelli F; Pelosi G; Sacchini D; Vaona GL; Zeneroli ML; Rocchi E; Santunione V; Gibertini P; Ventura E
    Ric Clin Lab; 1980; 10(2):411-22. PubMed ID: 7455531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of hepatic encephalopathy. Modification of the plasma aminogram using amino acid infusions].
    Ferenci P; Funovics J; Wewalka F
    Chir Forum Exp Klin Forsch; 1978; (1978):183-9. PubMed ID: 110563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma amino acids in hepatic encephalopathy.
    Ferenci P; Wewalka F
    J Neural Transm Suppl; 1978; (14):87-94. PubMed ID: 290744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach to nutritional therapy of hepatic encephalopathy by normalization of deranged amino acid patterns in serum.
    Watanabe A; Higashi T; Nagashima H
    Acta Med Okayama; 1978 Dec; 32(6):427-40. PubMed ID: 154828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations.
    Iwasaki Y; Sato H; Ohkubo A; Sanjo T; Futagawa S; Sugiura M; Tsuji S
    Gastroenterology; 1980 Apr; 78(4):677-83. PubMed ID: 6986317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BCAA/AAA ratio of plasma amino acids in three different groups of cirrhotics.
    Campollo O; Sprengers D; McIntyre N
    Rev Invest Clin; 1992; 44(4):513-8. PubMed ID: 1485030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of hepatic encephalopathy. Changes in the cerebrospinal fluid concentration of catecholamine neurotransmitters, ammonia and amino acids in the course of an infusion treatment with branched-chain amino acids].
    Rössle M; Herz R; Lehmann G; Luft M; Gerok W
    Infusionsther Klin Ernahr; 1982 Oct; 9(5):256-8. PubMed ID: 7141673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial.
    Sieg A; Walker S; Czygan P; Gärtner U; Lanzinger-Rossnagel G; Stiehl A; Kommerell B
    Z Gastroenterol; 1983 Nov; 21(11):644-50. PubMed ID: 6362243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of normalization of plasma amino acids on hepatic encephalopathy in man.
    Fischer JE; Rosen HM; Ebeid AM; James JH; Keane JM; Soeters PB
    Surgery; 1976 Jul; 80(1):77-91. PubMed ID: 818729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy (CHE) of patients with liver cirrhosis.
    Schäfer K; Winther MB; Ukida M; Leweling H; Reiter HJ; Bode JC
    Z Gastroenterol; 1981 Jul; 19(7):356-62. PubMed ID: 7293293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of branched-chain amino acid infusion on protein metabolism in rats with acute hepatic failure.
    Miwa Y; Kato M; Moriwaki H; Okuno M; Sugihara J; Ohnishi H; Yoshida T; Muto Y; Nakayama M; Morioka Y
    Hepatology; 1995 Jul; 22(1):291-6. PubMed ID: 7601423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma amino acid patterns in hepatic encephalopathy of differing etiology.
    Rosen HM; Yoshimura N; Hodgman JM; Fischer JE
    Gastroenterology; 1977 Mar; 72(3):483-7. PubMed ID: 832796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical study of an enteral branched-chain amino acid solution in decompensated liver cirrhosis with hepatic encephalopathy.
    Ichida T; Shibasaki K; Muto Y; Satoh S; Watanabe A; Ichida F
    Nutrition; 1995; 11(2 Suppl):238-44. PubMed ID: 7626911
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels.
    Bianchi GP; Marchesini G; Zoli M; Abbiati R; Ferrario E; Fabbri A; Pisi E
    Hepatogastroenterology; 1992 Oct; 39(5):443-6. PubMed ID: 1459529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
    Malaguarnera M; Risino C; Cammalleri L; Malaguarnera L; Astuto M; Vecchio I; Rampello L
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of branched-chain amino acid-enriched nutrient mixture on natural killer cell activity in viral cirrhosis.
    Takegoshi K; Nanasawa H; Itoh H; Yasuyama T; Ohmoto Y; Sugiyama K
    Arzneimittelforschung; 1998 Jun; 48(6):701-6. PubMed ID: 9689432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.